TCL Archive Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment December 29, 2006
TCL Archive In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid March 14, 1986